Licofelone

Known as: 6-(4-Chlorophenyl)-2,3-dihydro-2,2-dimethyl-7-phenyl-1H-pyrrolizine-5-acetic Acid, (2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl)acetic acid, 2,3-Dihydro-6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-1H-pyrrolizine-5-acetic Acid 
 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

ML-3000

Broader (1)

Pyrroles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury.
Inflammation is a major factor shaping outcome during the early, acute phase of traumatic spinal cord injury (SCI). It is known… (More)
  • table 1
  • table 1
  • table 1
  • table 2
  • figure 1
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI.
OBJECTIVE In a multicentre study to explore the effects of licofelone as a disease-modifying osteoarthritis drug in comparison… (More)
Is this relevant?
2008
2008
Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1.
The anti-inflammatory drug licofelone [=ML3000; 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2007
2007
The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products.
BACKGROUND AND PURPOSE Licofelone is a dual inhibitor of the cyclooxygenase and 5-lipoxygenase (5-LO) pathway, and has been… (More)
Is this relevant?
2007
2007
Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.
Licofelone, a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase (COX) enzymes, may have a better… (More)
  • table 1
Is this relevant?
2007
2007
Efficacy of licofelone in dogs with clinical osteoarthritis.
To evaluate the effect of licofelone, an arachidonic acid substrate with combined inhibitory activity against 5-lipoxygenase and… (More)
Is this relevant?
Review
2004
Review
2004
Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis.
Licofelone, a competitive inhibitor of 5-lipoxygenase, cyclooxygenase (COX)-1 and COX-2, is currently in clinical development for… (More)
Is this relevant?
2004
2004
The Gastrointestinal Tolerability of the LOX/COX Inhibitor, Licofelone, is Similar to Placebo and Superior to Naproxen Therapy in Healthy Volunteers: Results From a Randomized, Controlled Trial
OBJECTIVES:Concerns exist over the safety of conventional nonsteroidal antiinflammatory drugs (NSAIDs) and selective… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K.
OBJECTIVE To evaluate the morphological changes that take place in the subchondral bone and calcified cartilage zone in the… (More)
Is this relevant?
Review
2003
Review
2003
Licofelone (Merckle).
EuroAlliance (a consortium of Alfa Wassermann SpA, Lacer SA and Merckle GmbH) is developing licofelone, a dual cyclooxygenase and… (More)
Is this relevant?